查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1619613

2024 年医疗保健领域生成式人工智慧全球市场报告

Generative AI In Medicine Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

医疗保健领域的生成人工智慧 (AI) 市场规模预计将在未来几年呈指数级增长。 2028年，将以43.6%的复合年增长率成长至28.1亿美元。预测期内的预期增长是由于高品质医疗资料可用性的增加、对预防性护理的日益关注、对高效临床测试的需求不断增长以及在需求不断增长和使用不断增长的推动下转向人工智能增强型病人参与工具。预计影响这段时期的主要趋势包括技术进步、远端医疗、个人化医疗、预测分析和穿戴式医疗技术。

医疗保健领域的生成人工智慧 (AI) 市场的成长预计将受到数位健康记录的成长的推动。数位健康记录或电子健康记录(EHR) 是电子储存的病患健康资讯的系统集合，有助于医疗机构之间的共用并提高患者照护的效率和品质。数位健康记录的激增是由改善的患者照护、更有效率的医疗服务、监管支持和奖励、技术进步以及增加的患者参与和赋权所推动的。医疗保健领域的人工智慧透过自动化记录、组织资料、提供预测性见解和产生个人化摘要来增强数位健康记录，从而提高准确性、可近性和整体患者照护。例如，2024 年 7 月，欧盟委员会报告称，电子健康记录的访问率从 2023 年的 72% 增加到 2024 年的 79%。因此，数位医疗记录的兴起极大地推动了医疗保健领域的生成人工智慧市场的成长。

该市场的主要企业专注于开发创新技术，例如针对大脑健康和保健的人工智慧解决方案，以推进认知评估、改善患者照护并加强心理健康管理。针对大脑健康和保健的人工智慧解决方案是旨在评估、监测和改善认知功能和心理健康的先进技术。例如，2024 年 2 月，专门从事人工智慧数位治疗方法的加拿大公司 DiagnaMed Holdings Corp. 宣布推出 CERVAI，这是第一个针对人类心理健康和保健的人工智慧解决方案。该解决方案利用先进的人工智慧来全面评估认知功能和大脑健康。它具有最先进的演算法，可以分析各种资料输入，包括认知测试和大脑图像，并提供有关您的心理健康状况的准确见解。该工具提供个人化评估和可行的建议，促进认知问题的早期发现和量身定制的干预措施。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球医疗保健领域生成式人工智慧的市场驱动因素与限制
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023年全球医疗生成人工智慧市场规模表现与成长
  • 全球医疗保健领域生成式人工智慧的全球市场规模与成长预测，2023-2028 年、2033 年

第六章 市场细分

  • 2018-2023、2023-2028、2033 年医疗保健全球市场表现及预测（按组成部分）
  • 解决方案
  • 服务
  • 全球医疗保健生成人工智慧市场：按功能、效能和预测划分，2018-2023、2023-2028、2033
  • 虚拟护理助理
  • 机器人辅助AI手术
  • 优化管理流程
  • 医学影像分析
  • 全球医疗保健生成人工智慧市场：按应用、效能和预测，2018-2023、2023-2028、2033
  • 医学影像
  • 药物发现
  • 医学诊断
  • 患者资料分析
  • 其他的
  • 全球医疗保健生成人工智慧市场：最终用户的表现和预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 临床研究
  • 医疗机构
  • 诊断中心
  • 其他的

第 7 章 区域/国家分析

  • 全球医疗保健产生人工智慧市场，按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球医疗保健生成人工智慧市场，按国家、绩效和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 医疗保健领域产生人工智慧市场的竞争格局
  • 医疗保健生成人工智慧市场公司概况
    • Microsoft Corporation
    • Intel Corporation
    • International Business Machines Corporation
    • NVIDIA Corporation
    • Philips Healthcare

第三十一章 其他重大及创新企业

  • Veeva Systems Inc.
  • Nuance Communications Inc.
  • Babylon Health Ltd.
  • Tempus Labs Inc.
  • DeepMind Technologies Limited
  • Owkin Inc.
  • Viz.ai Inc.
  • Recursion Pharmaceuticals Inc.
  • Caresyntax Inc.
  • Relay Therapeutics Inc.
  • Exscientia plc
  • Paige AI Inc.
  • BenevolentAI Limited
  • Atomwise Inc.
  • Healx Ltd.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r20618

Generative artificial intelligence (AI) in medicine involves using AI systems to create new data, models, or insights to advance healthcare and medical research. Its goal is to enhance diagnosis, treatment, and overall patient care by leveraging data-driven insights and innovative solutions.

Key components of generative AI in medicine include solutions and services. In this context, solutions refer to the advanced technologies and tools designed to improve healthcare delivery and outcomes. These solutions cover a broad range of applications, such as AI-driven diagnostic tools, virtual nursing assistants, and platforms for medical imaging analysis. Key functions include virtual nursing assistants, robot-assisted AI surgery, administrative process optimization, and medical imaging analysis. Applications span medical imaging, drug discovery, medical diagnosis, patient data analysis, and more. These technologies are utilized by various end-users, including hospitals and clinics, clinical research organizations, healthcare organizations, diagnostic centers, and others.

The generative artificial intelligence (AI) in medicine market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in medicine market statistics, including generative artificial intelligence (AI) in medicine industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in medicine market share, detailed generative artificial intelligence (AI) in medicine market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in medicine industry. This generative artificial intelligence (AI) in medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generative artificial intelligence (AI) in medicine market size has grown exponentially in recent years. It will grow from $0.46 billion in 2023 to $0.66 billion in 2024 at a compound annual growth rate (CAGR) of 43.5%. The growth observed in the historic period can be attributed to increased computational power and advancements in machine learning algorithms, the expansion of precision medicine, a rising demand for drug discovery, greater adoption of AI in diagnostic imaging, and increased investment in AI research and development.

The generative artificial intelligence (AI) in medicine market size is expected to see exponential growth in the next few years. It will grow to $2.81 billion in 2028 at a compound annual growth rate (CAGR) of 43.6%. The anticipated growth during the forecast period is driven by the increasing availability of high-quality medical data, a heightened focus on preventive healthcare, the growing need for efficient clinical trials, rising demand for AI-enhanced patient engagement tools, and the expanding use of AI for drug repurposing. Key trends expected to shape this period include technological advancements, telemedicine, personalized medicine, predictive analytics, and wearable health technology.

The growth of the generative artificial intelligence (AI) in medicine market is expected to be driven by the increase in digital health records. Digital health records, or electronic health records (EHRs), are systematic collections of patient health information stored electronically, which facilitate sharing across healthcare settings and enhance the efficiency and quality of patient care. This surge in digital health records is fueled by improvements in patient care, greater efficiency in healthcare delivery, regulatory support and incentives, technological advancements, and enhanced patient engagement and empowerment. AI in medicine enhances digital health records by automating documentation, organizing data, providing predictive insights, and generating personalized summaries to improve accuracy, accessibility, and overall patient care. For example, in July 2024, the European Commission reported that access to electronic health records increased to 79% in 2024 from 72% in 2023. Thus, the rise in digital health records is significantly driving the growth of the generative AI in medicine market.

Leading companies in this market are concentrating on developing innovative technologies, such as AI solutions for brain health and wellness, to advance cognitive assessment, improve patient care, and enhance mental health management. AI solutions for brain health and wellness are advanced technologies designed to assess, monitor, and improve cognitive function and mental well-being. For instance, in February 2024, DiagnaMed Holdings Corp., a Canada-based company specializing in AI-powered digital therapeutics, launched CERVAI, the first AI solution for human mental health and wellness. This solution utilizes advanced AI to comprehensively evaluate cognitive function and brain wellness. It features cutting-edge algorithms that analyze various data inputs, including cognitive tests and brain imaging, to provide accurate insights into mental health conditions. The tool offers personalized assessments and actionable recommendations, facilitating early detection of cognitive issues and tailored interventions.

In March 2022, Microsoft Corporation, a US-based technology company, acquired Nuance Communications Inc. for an undisclosed amount. This acquisition aims to enhance Microsoft's AI-driven, cloud-based solutions across various industries, improving customer experiences and productivity through advanced conversational AI and ambient intelligence. Nuance Communications Inc., a US-based software technology corporation, focuses on integrating generative AI into the healthcare sector.

Major companies operating in the Generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.

North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Generative AI in medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Generative AI in medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in medicine market consists of revenues earned by entities providing services such as drug discovery and development, clinical trials, diagnostics, and virtual health assistants. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative artificial intelligence (AI) in medicine market also includes medical imaging analysis tools, drug discovery platforms, clinical decision support systems, patient data synthesis solutions, administrative automation software, and precision medicine applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative AI In Medicine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative AI in medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative AI in medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generative AI in medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Solutions; Service
  • 2) By Function: Virtual Nursing Assistants; Robot-Assisted AI Surgery; Administrative Process Optimization; Medical Imaging Analysis
  • 3) By Application: Medical Imaging; Drug Discovery; Medical Diagnosis; Patient Data Analysis; Other Applications
  • 4) By End-User: Hospitals And Clinics; Clinical Research; Healthcare Organizations; Diagnostic Centers; Other End-Users
  • Companies Mentioned: Microsoft Corporation; Intel Corporation; International Business Machines Corporation; NVIDIA Corporation; Philips Healthcare
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Generative Artificial Intelligence (AI) In Medicine Market Characteristics

3. Generative Artificial Intelligence (AI) In Medicine Market Trends And Strategies

4. Generative Artificial Intelligence (AI) In Medicine Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Generative Artificial Intelligence (AI) In Medicine Market Size and Growth

  • 5.1. Global Generative Artificial Intelligence (AI) In Medicine Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Generative Artificial Intelligence (AI) In Medicine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Generative Artificial Intelligence (AI) In Medicine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Generative Artificial Intelligence (AI) In Medicine Market Segmentation

  • 6.1. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Solutions
  • Service
  • 6.2. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Function, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Virtual Nursing Assistants
  • Robot-Assisted AI Surgery
  • Administrative Process Optimization
  • Medical Imaging Analysis
  • 6.3. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medical Imaging
  • Drug Discovery
  • Medical Diagnosis
  • Patient Data Analysis
  • Other Applications
  • 6.4. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Clinical Research
  • Healthcare Organizations
  • Diagnostic Centers
  • Other End-Users

7. Generative Artificial Intelligence (AI) In Medicine Market Regional And Country Analysis

  • 7.1. Global Generative Artificial Intelligence (AI) In Medicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Generative Artificial Intelligence (AI) In Medicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market

  • 8.1. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Generative Artificial Intelligence (AI) In Medicine Market

  • 9.1. China Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 9.2. China Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Generative Artificial Intelligence (AI) In Medicine Market

  • 10.1. India Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Generative Artificial Intelligence (AI) In Medicine Market

  • 11.1. Japan Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 11.2. Japan Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Generative Artificial Intelligence (AI) In Medicine Market

  • 12.1. Australia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Generative Artificial Intelligence (AI) In Medicine Market

  • 13.1. Indonesia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Generative Artificial Intelligence (AI) In Medicine Market

  • 14.1. South Korea Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 14.2. South Korea Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Generative Artificial Intelligence (AI) In Medicine Market

  • 15.1. Western Europe Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 15.2. Western Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Generative Artificial Intelligence (AI) In Medicine Market

  • 16.1. UK Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Generative Artificial Intelligence (AI) In Medicine Market

  • 17.1. Germany Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Generative Artificial Intelligence (AI) In Medicine Market

  • 18.1. France Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Generative Artificial Intelligence (AI) In Medicine Market

  • 19.1. Italy Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Generative Artificial Intelligence (AI) In Medicine Market

  • 20.1. Spain Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market

  • 21.1. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 21.2. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Generative Artificial Intelligence (AI) In Medicine Market

  • 22.1. Russia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Generative Artificial Intelligence (AI) In Medicine Market

  • 23.1. North America Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 23.2. North America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Generative Artificial Intelligence (AI) In Medicine Market

  • 24.1. USA Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 24.2. USA Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Generative Artificial Intelligence (AI) In Medicine Market

  • 25.1. Canada Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 25.2. Canada Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Generative Artificial Intelligence (AI) In Medicine Market

  • 26.1. South America Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 26.2. South America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Generative Artificial Intelligence (AI) In Medicine Market

  • 27.1. Brazil Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Generative Artificial Intelligence (AI) In Medicine Market

  • 28.1. Middle East Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 28.2. Middle East Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Generative Artificial Intelligence (AI) In Medicine Market

  • 29.1. Africa Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 29.2. Africa Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Generative Artificial Intelligence (AI) In Medicine Market Competitive Landscape And Company Profiles

  • 30.1. Generative Artificial Intelligence (AI) In Medicine Market Competitive Landscape
  • 30.2. Generative Artificial Intelligence (AI) In Medicine Market Company Profiles
    • 30.2.1. Microsoft Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Intel Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. International Business Machines Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. NVIDIA Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Philips Healthcare
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Generative Artificial Intelligence (AI) In Medicine Market Other Major And Innovative Companies

  • 31.1. Veeva Systems Inc.
  • 31.2. Nuance Communications Inc.
  • 31.3. Babylon Health Ltd.
  • 31.4. Tempus Labs Inc.
  • 31.5. DeepMind Technologies Limited
  • 31.6. Owkin Inc.
  • 31.7. Viz.ai Inc.
  • 31.8. Recursion Pharmaceuticals Inc.
  • 31.9. Caresyntax Inc.
  • 31.10. Relay Therapeutics Inc.
  • 31.11. Exscientia plc
  • 31.12. Paige AI Inc.
  • 31.13. BenevolentAI Limited
  • 31.14. Atomwise Inc.
  • 31.15. Healx Ltd.

32. Global Generative Artificial Intelligence (AI) In Medicine Market Competitive Benchmarking

33. Global Generative Artificial Intelligence (AI) In Medicine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Medicine Market

35. Generative Artificial Intelligence (AI) In Medicine Market Future Outlook and Potential Analysis

  • 35.1 Generative Artificial Intelligence (AI) In Medicine Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Generative Artificial Intelligence (AI) In Medicine Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Generative Artificial Intelligence (AI) In Medicine Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer